Falkman , Lovisa, et al. “Genetics-Guided Therapy in Neuroendocrine Carcinoma: Response to BRAF- and MEK-Inhibitors”. Upsala Journal of Medical Sciences, vol. 129, no. S1, Apr. 2024, p. e10660, doi:10.48101/ujms.v129.10660.